Outcomes, no. of events (event rate /100 person-years) | Total (n = 1089) | Development cohort (n = 762) | Validation cohort (n = 327) | P |
---|---|---|---|---|
Follow-up, months | 36.0 (18.0, 71.0) | 36.5 (18.0, 71.0) | 35.0 (16.0, 72.0) | 0.710 |
Death | 490 (11.1) | 346 (11.1) | 144 (11.0) | 0.888 |
 Cardiovascular events | 197 (4.5) | 139 (4.5) | 58 (4.4) | 0.407 |
 Infection | 121 (2.7) | 95 (3.1) | 26 (2.0) | 0.219 |
 Tumor | 43 (1.0) | 27 (0.9) | 16 (1.2) | 0.150 |
 Severe malnutrition | 23 (0.5) | 13 (0.4) | 10 (0.8) | 0.060 |
 Others | 105 (2.4) | 72 (2.3) | 33 (2.5) | 0.643 |
Transfer to hemodialysis | 191 (4.3) | 138 (4.4) | 53 (4.1) | 0.549 |
 PD-related infection | 109 (2.5) | 74 (2.4) | 35 (2.7) | 0.508 |
 Fluid overload | 15 (0.3) | 12 (0.4) | 3 (0.2) | 0.216 |
 Inadequate solute clearance | 13 (0.3) | 8 (0.3) | 5 (0.4) | 0.661 |
 Leak | 11 (0.2) | 8 (0.3) | 3 (0.2) | 0.852 |
 Socioeconomic issue | 27 (0.6) | 24 (0.8) | 3 (0.2) | 0.025 |
 Others | 15 (0.3) | 11 (0.4) | 4 (0.3) | 0.051 |
Renal transplantation | 137 (3.1) | 89 (2.9) | 48 (3.7) | 0.172 |
Lost to follow-up | 30 (0.7) | 20 (0.6) | 10 (0.8) | 0.646 |